News on research grants, RFPs, government funding trends in genetics, genomics, and molecular diagnostics.
The grant is specifically intended to support the development of noninvasive, rapid tests that can be used at the point of care in developing country settings.
The prize is awarded to research teams around the world that are attempting to develop a point-of-care test help further reduce the spread of drug-resistant bacteria.
The semifinalists will receive $50,000 each to develop prototypes of their concepts for submission in the second phase of the challenge.
The funding builds on more than $1.7 million already awarded to the firm, which is building a diagnostic for characterizing patients in clinical trials.
The funding will advance work focused on the discovery of a genomic configuration that correlates to chemotherapy sensitivity.
